Pineapple Express Cannabis (PNXP) Return on Capital Employed (2018 - 2025)
Pineapple Express Cannabis' (PNXP) quarterly Return on Capital Employed came in at 4.12% in Q4 2025, up 3889.0% year-on-year from 0.1% in Q4 2024, and down 24.8% quarter-over-quarter from 5.48% in Q3 2025.
Pineapple Express Cannabis (PNXP) Return on Capital Employed (2018 - 2025) Analysis & Trends
Pineapple Express Cannabis has disclosed Return on Capital Employed across 8 years of filings, most recently posting 4.12% for Q4 2025.
- Return on Capital Employed for Q4 2025 came in at 4.12%, up 3889.0% year-over-year; the trailing twelve-month figure through Oct 2025 was 4.12% (up 3889.0% YoY), and the FY2024 annual result was 378.67%, up 37563.0% from the prior year.
- Return on Capital Employed came in at 4.12% for Q4 2025 at Pineapple Express Cannabis, down from 5.48% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 142.07% in Q3 2022 to a low of 180.91% in Q2 2021.
- The 5-year median for Return on Capital Employed is 3.53% (2023), against an average of 7.19%.
- Across the five-year window, Return on Capital Employed soared 29826 bps in 2022 and sank 15156 bps in 2023, its largest moves.
- Pineapple Express Cannabis' Return on Capital Employed stood at 138.66% in 2021, then jumped by 201 bps to 140.57% in 2022, then plunged by 104 bps to 5.72% in 2023, then plunged by 508 bps to 34.76% in 2024, then jumped by 112 bps to 4.12% in 2025.
- The last three Return on Capital Employed figures came in at 4.12% (Q4 2025), 5.48% (Q3 2025), and 34.76% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Pineapple Express Cannabis | - | - | - | 4.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 4.12% |
| Jul 31, 2025 | 5.48% |
| Oct 31, 2024 | -34.76% |
| Jul 31, 2024 | -0.96% |
| Apr 30, 2024 | -1.34% |
| Jan 31, 2024 | -11.42% |
| Oct 31, 2023 | -5.72% |
| Jul 31, 2023 | -9.49% |
| Apr 30, 2023 | -28.02% |
| Jan 31, 2023 | 3.02% |
| Oct 31, 2022 | 140.57% |
| Jul 31, 2022 | 142.07% |
| Apr 30, 2022 | 109.53% |
| Jan 31, 2022 | 78.43% |
| Oct 31, 2021 | -138.66% |
| Jul 31, 2021 | -156.19% |
| Apr 30, 2021 | -180.91% |
| Jan 31, 2021 | -45.11% |
| Oct 31, 2020 | -22.94% |
| Jul 31, 2020 | -71.42% |